Why I Don’t Invest in the Drug Makers
Today and yesterday on CNBC I keep hearing about how managed healthcare and price controls on drugs are going to spell the end of research today. It is a very very tiring argument. My sister about fifteen years ago dated a PHD student that was a cancer researcher and he told me an interesting...
Read More →